EAHAD 2024: Interim Results of the First-in-Human Investigation of HMB-001 for Prophylactic Management of Glanzmann Thrombasthenia

February 6, 2024
July 22, 2025

Presented at 17th Annual Congress of the European Association of Haemophilia and Allied Disorders

To view the presentation, click here